Literature DB >> 2405263

Photobiological effects in Saccharomyces cerevisiae induced by the monofunctional furocoumarin 4,4',6-trimethylangelicin (TMA) and the bifunctional furocoumarin 8-methoxypsoralen (8-MOP).

L Bianchi1, A Bianchi, F Dall'Acqua, L Santamaria.   

Abstract

Recently, the monofunctional furocoumarin 4,4',6-trimethylangelicin (TMA) has been proposed for photochemotherapeutic use. In order to assess its genotoxic potential, the photobiological (genetic) effects of TMA were studied in a diploid strain of Saccharomyces cerevisiae (D7) and compared to those of the bifunctional furocoumarin 8-methoxypsoralen (8-MOP). At equimolar concentrations, the induction of lethal effects by TMA in the presence of equal 365-nm radiation was higher than that exerted by 8-MOP. TMA was also more active than 8-MOP in inducing nuclear events such as nuclear reverse mutation and mitotic recombination (crossing-overs and gene conversion) per unit dose of 365-nm radiation. At equal survival, however, TMA was less efficient in inducing reverse mutation and crossing-over, showing the same activity as 8-MOP in the induction of gene conversion. TMA was more active than 8-MOP in the induction of cytoplasmic 'petite' mutations per unit dose of 365-nm radiation and per viable cell. The high photobiological activity of this monofunctional furocoumarin is mainly related to its strong DNA photobinding but also to the type of monoaddition induced, to the sequential distribution in DNA and to the generation of active forms of oxygen.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2405263     DOI: 10.1016/0921-8777(90)90016-x

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  1 in total

1.  Molecular Mechanism of Action of Trimethylangelicin Derivatives as CFTR Modulators.

Authors:  Onofrio Laselva; Giovanni Marzaro; Christian Vaccarin; Ilaria Lampronti; Anna Tamanini; Giuseppe Lippi; Roberto Gambari; Giulio Cabrini; Christine E Bear; Adriana Chilin; Maria C Dechecchi
Journal:  Front Pharmacol       Date:  2018-07-04       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.